Sublingual swallow immunotherapy in the new world

Annals of Allergy, Asthma and Immunology

Volumn 93, Issue 5, 2004, Pages 405-406

  Norman, Philip S ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; GRASS POLLEN EXTRACT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; IMMUNOLOGIC AGENT; RAGWEED ANTIGEN;

ALLERGIC RHINITIS; ANAPHYLAXIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EDITORIAL; GASTROINTESTINAL DISEASE; GLOSSITIS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; NAUSEA; PRIORITY JOURNAL; PRURITUS; T LYMPHOCYTE; TREATMENT WITHDRAWAL;

EID: 8644226922     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61404-4     Document Type: Editorial

References (4)

1. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol. 2003;111:437-448.
2. Bowen T, Greenbaum J, Charbonneau Y, et al. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis. Ann Allergy Asthma Immunol. 2004;93:425-430.
3. Fanta C, Hirt W, Siemann U, et al. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol. 1999;120:218-224.
4. Norman PS. Immunotherapy: 1999-2004. J Allergy Clin Immunol. 2004;113:1013-1023.